Breyanzi: CAR T-cell Therapy Gets Positive CHMP Opinion for R/R Large B-Cell Lymphoma Manali Kamdar, MD - Synopsis below extracted from the video transcript.
Polatuzumab Vedotin: How does the Polarix trial contribute to our understanding of DLBCL? Connor Johnson MD - Synopsis below extracted from the video transcript.
Tafasitamab: Final Results of Five-Year Safety and Efficacy Study (Phase II L-MIND) Prof. Kalakonda - Synopsis below extracted from the video transcript.
Chimeric Antigen Receptor T-Cell Therapy: A Longitudinal Study Connor Johnson MD - Synopsis below extracted from the video transcript.
"Chimeric Antigen Receptor T-Cell Therapy: A Longitudinal Study" by Dr. Connor Johnson provides an overview of the use of CAR-T cell therapy in treating patients with B-cell malignancies. CAR-T cell therapy involves re-engineering a patient's own immune cells to recognize and attack cancer cells. Dr. Johnson discusses his experience treating patients with CAR-T cell therapy and the results of a longitudinal study that followed patients over a period of several years.
How effective is mosunetuzumab in treating lymphoma? - [Slides] Elizabeth Budde, MD 2023 reviews new therapies - Synopsis below extracted from the video transcript.